Dapagliflozin
Dapagliflozin DAPAGLIFLOZIN An SGLT-2 inhibitor drug of gliflozin class. Used in type 2 diabetes treatment. Efficacy & safety yet to be proved. MECHANISM OF ACTION: Glucose is reabsorbed completely in proximal tubules by sodium-glucose cotransporter-2 [SGLT-2]. Dapagliflozin acts by inhibiting SGLT-2 transporter. METABOLISM: Are effective orally. Effects: Single daily dose produces continuous glucosuria lowering blood glucose levels. SIDE EFFECTS: Main effects: Heavy […]


